SCHEMBL2441805

SCHEMBL2441805

O=C(Nc1ccc2ccccc2c1)c1noc2c(F)cccc12

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 11/20 0.68
NPC1 O15118 7/20 0.55
RAB9A P51151 7/20 0.55
KDM4E B2RXH2 2/20 0.50
CASP3 P42574 2/20 0.50
SENP7 Q9BQF6 2/20 0.50
SENP6 Q9GZR1 2/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
CYP1A2 P05177 1/20 0.48
NFKB1 P19838 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
SENP8 Q96LD8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2441850 0.79 HIF1A (0.76) HIF1ANPC1RAB9AKDM4ECASP3
SCHEMBL2442815 0.74 KDM4C (0.42) HIF1ANPC1RAB9ASMN1; SMN2
SCHEMBL2448406 0.74 HIF1A (0.76) HIF1ANPC1RAB9AKDM4ECASP3
SCHEMBL2442149 0.72 KDM4E (0.45) HIF1ANPC1RAB9AKDM4EMEN1
SCHEMBL13209719 0.72 SSTR4 (0.41) HIF1ANPC1RAB9ASMN1; SMN2
SCHEMBL13209752 0.70 SSTR4 (0.43) HIF1ANPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL15426975 0.70 SMN1; SMN2 (0.74) NPC1RAB9AMEN1KMT2ACYP1A2
SCHEMBL24174035 0.70 SSTR4 (0.43) HIF1ANPC1RAB9AKDM4EKMT2A
SCHEMBL2438808 0.70 HIF1A (0.65) HIF1ANPC1RAB9AKDM4ECASP3
SCHEMBL18027619 0.69 NPC1 (0.78) NPC1RAB9AKDM4ECASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP claimed
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof GRUENENTHAL GMBH (DE) 2008-12-18 US claimed
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof HTR5A, NPY5R, GRM5 HIF1A 2528/4885NPC1 1395/4885RAB9A 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.